Pulse Explorar nav.journalClub Debates Tendências Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging | Synapse

August 16, 2023Open Access

Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

Key Points

Key points are not available for this paper at this time.

Abstract

Findings estimate the limited eligibility in typical older adults with cognitive impairment for anti-β-amyloid mAbs.

Read Full Paperexternally

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Pittock et al. (Wed,) studied this question.

synapsesocial.com/papers/69137fe3082dbf75c34cbbe7 https://doi.org/https://doi.org/10.1212/wnl.0000000000207770

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cerebral microbleeds: a guide to detection and interpretation2009 · 1,806 citations
2External validity of randomised controlled trials: “To whom do the results of this trial apply?”2005 · 2,522 citations
3Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study2021 · 118 citations
4Establishing a Framework for Gathering Structural and Social Determinants of Health in Alzheimer’s Disease Research Centers2021 · 64 citations
5Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia2019 · 339 citations